Partnership to develop new cryopreservation systems for the advancement of human blood services and advanced cellular therapies
From new assays to new ways of looking at donations, BBG R&D is making an impact.
This whitepaper goes through five testing strategies that QualTex Laboratories use to help customers in the cell and cell-based therapy industry.
A six-step roadmap to help you identify a laboratory testing partner
South Texas Blood & Tissue Center’s tissue recovery team has been named the nation’s top program for recovering cardio vascular tissue for CryoLife, an organization that provides tissue for cardiac and vascular surgeries.
Although the advanced therapies industry is not new, no harmonised testing standards are currently available to align the industry.
Virtually everyone in a study in the United Kingdom who had COVID-19 still had antibodies to it in their systems three months after recovering, and almost nine in 10 had them after six months.
An Interview with Ward Carter, Chief Operating Officer, QualTex Laboratories
The Ortho Diagnostics Test detects antibodies developed during a COVID-19 infection QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global, has begun offering the Ortho Diagnostics VITROS®
Lab to support researchers developing new treatments for global healthcare market including cellular therapy QualTex Laboratories, a subsidiary of the San Antonio-based nonprofit BioBridge Global,
Partners GenCure, Sentien, & RoosterBio will develop potency assay for mesenchymal stromal cells The federal Medical Technology Enterprise Consortium (MTEC) has identified the need for
Community Labs soon will be performing up to 10,000 COVID-19 tests a day and expects to reach capacity of 20,000 or more per day by January.
